Mach 1 Financial Group, LLC Exact Sciences Corp Transaction History

Mach 1 Financial Group, LLC

  • $140 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024
SELL
$59.06 - $75.72 $43,822 - $56,184
-742 Reduced 9.89%
6,758 $499,000
Q3 2023

Oct 17, 2023
SELL
$65.94 - $99.04 $110,515 - $165,991
-1,676 Reduced 18.27%
7,500 $511,000
Q2 2023

Jul 28, 2023
BUY
$62.68 - $95.05 $575,151 - $872,178
9,176 New
9,176 $861,000

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Mach 1 Financial Group, LLC Portfolio

Follow Mach 1 Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mach 1 Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mach 1 Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email